Injective just dropped its own native EVM, and honestly, that’s a pretty big deal for DeFi. It unlocks Injective’s MultiVM idea in full—so building apps on-chain just got a whole lot easier and more flexible. Over 40 dApps and infrastructure teams are already jumping in, so you can feel the momentum picking up fast.

Then there’s Pineapple Financial. They’re a public company on the New York Stock Exchange, and they’ve set up a $100 million digital asset treasury just to buy INJ, right out in the open market. That’s not just a splashy headline—it’s real institutional money backing Injective.

And get this: there’s an Injective ETF coming soon in the US. That means both big investors and regular folks will be able to get their hands on INJ through Wall Street, making it way easier to bridge the old-school financial world with the new one.

Injective isn’t stopping there. They’re pushing real-world assets—think stocks, gold, foreign exchange, and more—onto the blockchain. Suddenly, anyone can get involved in on-chain economies, not just crypto diehards.

They're also rolling out brand-new institutional assets. Injective is first in line to tokenize things like digital asset treasuries and even stocks—Nvidia, for example. It’s a major move for tokenization, opening up opportunities we haven’t really seen before.

If you want to check all this out, Binance has you covered. The Binance ecosystem makes it simple to get involved with INJ and all these new features.

Bottom line: Injective’s native EVM, its push for RWA tokenization, and easier institutional access through an ETF are all driving onchain finance forward—especially if you’re using Binance.
@Injective #Injective $INJ